Literature DB >> 17121919

Cantharidin-induced mitotic arrest is associated with the formation of aberrant mitotic spindles and lagging chromosomes resulting, in part, from the suppression of PP2Aalpha.

Kathy Bonness1, Ileana V Aragon, Beth Rutland, Solomon Ofori-Acquah, Nicholas M Dean, Richard E Honkanen.   

Abstract

Cantharidin, a natural vesicant, inhibits the activity of several PPP family phosphatases, displays antitumor activity, and induces apoptosis in many types of tumor cells. However, the molecular mechanisms underlying the antitumor activity of cantharidin are not clear. Here, dose-response studies confirm a strong correlation between the suppression of phosphatase activity and cell death. Flow cytometry analysis indicates that before apoptosis, cantharidin delays cell cycle progression following DNA replication with no apparent effect on G(1)-S or S-G(2) phase progression. In contrast, studies with double thymidine-synchronized populations of cells indicate that cantharidin can rapidly arrest growth when added during G(2) or early M phase. Immunostaining indicates that cell cycle arrest occurs before the completion of mitosis and is associated with the appearance of aberrant mitotic spindles. Live cell imaging with time-lapse microscopy shows that cantharidin disrupts the metaphase alignment of chromosomes and produces a prolonged mitotic arrest, with the onset of apoptosis occurring before the onset of anaphase. To explore the contribution of individual phosphatases, antisense oligonucleotides and small interfering RNA were developed to suppress the expression of cantharidin-sensitive phosphatases. The suppression of PP2Aalpha, but not PP2Abeta, is sufficient to induce metaphase arrest, during which time lagging chromosomes are observed moving between the spindle poles and the metaphase plate. Immunostaining revealed slightly abnormal, yet predominately bipolar, mitotic spindles. Nonetheless, after a 10- to 15-hour delay, the cells enter anaphase, suggesting that an additional cantharidin-sensitive phosphatase is involved in the progression from metaphase into anaphase or to prevent the onset of apoptosis in cells arrested during mitosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17121919      PMCID: PMC4261662          DOI: 10.1158/1535-7163.MCT-06-0273

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  33 in total

Review 1.  Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies.

Authors:  Adam McCluskey; Alistair T R Sim; Jennette A Sakoff
Journal:  J Med Chem       Date:  2002-03-14       Impact factor: 7.446

2.  Cytotoxic effects of cantharidin on the growth of normal and carcinoma cells.

Authors:  C C Wang; C H Wu; K J Hsieh; K Y Yen; L L Yang
Journal:  Toxicology       Date:  2000-06-08       Impact factor: 4.221

3.  Serine/threonine protein phosphatase type 5 acts upstream of p53 to regulate the induction of p21(WAF1/Cip1) and mediate growth arrest.

Authors:  Z Zuo; N M Dean; R E Honkanen
Journal:  J Biol Chem       Date:  1998-05-15       Impact factor: 5.157

Review 4.  Segregating sister genomes: the molecular biology of chromosome separation.

Authors:  Kim Nasmyth
Journal:  Science       Date:  2002-07-26       Impact factor: 47.728

5.  Cantharidin, another natural toxin that inhibits the activity of serine/threonine protein phosphatases types 1 and 2A.

Authors:  R E Honkanen
Journal:  FEBS Lett       Date:  1993-09-20       Impact factor: 4.124

6.  Fundamental role of the fostriecin unsaturated lactone and implications for selective protein phosphatase inhibition.

Authors:  Suzanne B Buck; Christophe Hardouin; Satoshi Ichikawa; Danielle R Soenen; C-M Gauss; Inkyu Hwang; Mark R Swingle; Kathy M Bonness; Richard E Honkanen; Dale L Boger
Journal:  J Am Chem Soc       Date:  2003-12-24       Impact factor: 15.419

7.  Roles of p38 and JNK mitogen-activated protein kinase pathways during cantharidin-induced apoptosis in U937 cells.

Authors:  Jeong-Eun Huh; Kyung-Sun Kang; Chanhee Chae; Hyung-Min Kim; Kyoo-Seok Ahn; Sung-Hoon Kim
Journal:  Biochem Pharmacol       Date:  2004-05-15       Impact factor: 5.858

8.  Identification of a functional link for the p53 tumor suppressor protein in dexamethasone-induced growth suppression.

Authors:  Gudrun Urban; Teresa Golden; Ileana V Aragon; Lex Cowsert; Scott R Cooper; Nicholas M Dean; Richard E Honkanen
Journal:  J Biol Chem       Date:  2003-01-07       Impact factor: 5.157

Review 9.  Medical uses of mylabris in ancient China and recent studies.

Authors:  G S Wang
Journal:  J Ethnopharmacol       Date:  1989-09       Impact factor: 4.360

10.  Partial characterization of specific cantharidin binding sites in mouse tissues.

Authors:  M J Graziano; I N Pessah; M Matsuzawa; J E Casida
Journal:  Mol Pharmacol       Date:  1988-06       Impact factor: 4.436

View more
  24 in total

1.  Inhibition of serine/threonine phosphatase PP2A enhances cancer chemotherapy by blocking DNA damage induced defense mechanisms.

Authors:  Jie Lu; John S Kovach; Francis Johnson; Jeffrey Chiang; Richard Hodes; Russell Lonser; Zhengping Zhuang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-29       Impact factor: 11.205

2.  The Antitumor Drug LB-100 Is a Catalytic Inhibitor of Protein Phosphatase 2A (PPP2CA) and 5 (PPP5C) Coordinating with the Active-Site Catalytic Metals in PPP5C.

Authors:  Brandon M D'Arcy; Mark R Swingle; Cinta M Papke; Kevin A Abney; Erin S Bouska; Aishwarya Prakash; Richard E Honkanen
Journal:  Mol Cancer Ther       Date:  2019-01-24       Impact factor: 6.261

3.  Norcantharidin impairs medulloblastoma growth by inhibition of Wnt/β-catenin signaling.

Authors:  Flora Cimmino; Maria Nunzia Scoppettuolo; Marianeve Carotenuto; Pasqualino De Antonellis; Valeria Di Dato; Gennaro De Vita; Massimo Zollo
Journal:  J Neurooncol       Date:  2011-07-07       Impact factor: 4.130

4.  Microcystin-LR, a protein phosphatase inhibitor, induces alterations in mitotic chromatin and microtubule organization leading to the formation of micronuclei in Vicia faba.

Authors:  Dániel Beyer; Ildikó Tándor; Zoltán Kónya; Róbert Bátori; Janos Roszik; György Vereb; Ferenc Erdodi; Gábor Vasas; Márta M-Hamvas; Károly Jambrovics; Csaba Máthé
Journal:  Ann Bot       Date:  2012-07-20       Impact factor: 4.357

Review 5.  LB100, a small molecule inhibitor of PP2A with potent chemo- and radio-sensitizing potential.

Authors:  Christopher S Hong; Winson Ho; Chao Zhang; Chunzhang Yang; J Bradley Elder; Zhengping Zhuang
Journal:  Cancer Biol Ther       Date:  2015-04-21       Impact factor: 4.742

6.  Traditional Chinese medicine in the prevention and treatment of cancer and cancer metastasis.

Authors:  Lin Ye; Yongning Jia; K E Ji; Andrew J Sanders; Kan Xue; Jiafu Ji; Malcolm D Mason; Wen G Jiang
Journal:  Oncol Lett       Date:  2015-07-06       Impact factor: 2.967

7.  Inhibition of Protein Phosphatase 2A Sensitizes Mucoepidermoid Carcinoma to Chemotherapy via the PI3K-AKT Pathway in Response to Insulin Stimulus.

Authors:  Limin Liu; Herui Wang; Jing Cui; Qi Zhang; Wei Zhang; Wanlin Xu; Hao Lu; Shengwen Liu; Shukun Shen; Francia Fang; Lei Li; Wenjun Yang; Zhengping Zhuang; Jiang Li
Journal:  Cell Physiol Biochem       Date:  2018-10-03

8.  Suppression of Ser/Thr phosphatase 4 (PP4C/PPP4C) mimics a novel post-mitotic action of fostriecin, producing mitotic slippage followed by tetraploid cell death.

Authors:  Benjamin Theobald; Kathy Bonness; Alla Musiyenko; Joel F Andrews; Gudrun Urban; Xizhong Huang; Nicholas M Dean; Richard E Honkanen
Journal:  Mol Cancer Res       Date:  2013-05-13       Impact factor: 5.852

Review 9.  Antitumor potential of the protein phosphatase inhibitor, cantharidin, and selected derivatives.

Authors:  Yulin Ren; A Douglas Kinghorn
Journal:  Bioorg Med Chem       Date:  2021-01-09       Impact factor: 3.641

10.  Leucine carboxyl methyltransferase-1 is necessary for normal progression through mitosis in mammalian cells.

Authors:  Jocelyn A Lee; David C Pallas
Journal:  J Biol Chem       Date:  2007-08-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.